CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo

CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo
fkansteiner
Tue, 03/01/2022 – 09:57